N-terminally acetylated Leu-enkephalin acts as an agonist for opioid receptors, particularly serving as an endogenous ligand for delta opioid receptors; it is involved in opioid signaling pathways in the spinal dorsal horn and has been pharmacologically characterized in nervous tissues with high affinity for δ-type opioid receptors (e.g., Ki = 18.9 nM for Leu-enkephalin).